Investment Opportunity International’s ‘Global Library of Medicine’ is Providing the Health Answers Billions Are Searching For

Treatment.Com | Listed on: CSE: | OTC:TREIF | XBER:939.BE

With more than a billion health-related searches made on Google every single day, International’s super-intelligent AI platform—known as the ‘Global Library of Medicine’—looks to store effective and personally-tailored medical advice so that people can more accurately self-diagnose themselves. In a world where seeing a doctor is becoming harder and harder, and treatment is becoming more and more expensive, it could be a game-changer.

Why You Should Consider Investing Today

  • Huge, pent-up demand for Treatment’s offering

    One billion health related searches are made on Google every day, proving there is huge demand for better self-diagnostic tools.

  • Market leading AI created with real doctors

    The Global Library of Medicine AI has been developed and trained by more than 60 doctors and 75 engineers, making it truly unique.

  • University approved after extensive testing

    The University of Minnesota has already licensed the Treatment Mobile app—the first product to use the AI—to help educate its own medical students.

  • Timely opportunity before mass adoption

    Imminent launch of state-of-the-art Treatment Mobile app could act as a significant catalyst for a positive rerate in Treatment’s valuation.

  • Company is massively discounted against peers

    Comparable businesses have greater valuations, yet their products and services are arguably not as advanced.

  • Immense experience leading the way

    CEO and president John Fraser has already successfully taken one health-tech company from start-up to a $1.2 billion sale.

Access our special report today to discover in more detail just how exciting an opportunity Treatment represents for smart investors. The time to take advantage is now.

Get the report

What You Need to Know: With Over a Billion Searches Every Day, Healthcare is Crying Out For a Universal Solution


When it comes to our health, there’s huge demand for better self-diagnosis tools.

You only need to look at the fact that more than one billion health-related searches are made on Google every day to see this.

With doctors becoming harder to see, and treatments more expensive, people are frankly desperate to figure out what’s wrong with them and find a cost-effective way of fixing the situation.

Trouble is, trying to self-diagnosing ailments on a platform like Google can be dangerous.

You see, when we enter our details on a generic search engine, there’s no way it can return results nuanced to our personal circumstances. Indeed, it’s often the case that you might read something that makes you think you’re suffering from one particular health problem, when—in reality—you’re experiencing something completely different.

Obviously, this is dangerous as it’s possible people might misdiagnose and prescribe themselves the wrong medicine, or they might miss a major health issue altogether.

And all this is why Treatment’s AI platform, known as the Global Library of Medicine, could be such a game-changer. 

Through a series of diagnostic questions, it is able to figure out exactly what is wrong with someone and guide them towards the best treatment.

But what really sets it aside is the fact that it’s been developed with the help of more than 60 doctors (as well as 75 engineers) to react and interpret certain information, and guide patients through the treatment process, in exactly the same way a medical professional would. 

In other words, the Global Library of Medicine has been built to ‘think like a doctor’, and this is why it’s so effective.

Indeed, there’s no wonder the University of Minnesota—one of America’s leading medical universities—has already started using the AI to train its own doctors.

To discover the full story and see just why the University of Minnesota is so impressed by what Treatment has developed, access our special report now.


What You Need to Know: As the Global Library of Medicine Grows, So Do the Potential Revenue Streams


As well as helping people around the world make better health decisions, the Global Library of Medicine also stands to be transformational for Treatment’s balance sheet. 

You see, the nature of the platform means the company can take advantage of a number of different revenue streams, and investors who choose to investigate further will soon see that the potential here is enormous.

To start with, Treatment is launching a specific app that people can use as a self-diagnosing help tool. It’s called Treatment Mobile, and essentially it acts like a combination of a health monitor and doctor, all rolled into one.

Powered by the Global Library of Medicine, Treatment Mobile learns about users and monitors their health on an ongoing basis. When someone uses it to self-diagnose a health problem, not only does it react, but it actively monitors the person to see how their health improves.

The Treatment Mobile app is one initial way Treatment can quickly monetize its AI, but there is a much greater source of revenue to be had over the long term.

You see, as the Global Library of Medicine AI platform learns more and more about various health issues and grows, it can be used to create a whole suite of products and applications that can be used by individuals, companies, and even government organizations.

Indeed, Treatment plans to launch ‘Global Library of Medicine’-powered products for use in everything from doctor-focused triage to dermatology and ophthalmology.

And of course, as revenue generating products like this become more and more widely used, the ‘Global Library of Medicine’ becomes even bigger and more intelligent, putting Treatment in a stronger and stronger position.

When you consider the global healthcare industry is worth over $11 trillion and you think about just how big a slice of that Treatment could potentially take with such a ground-breaking piece of technology, you soon realize the sheer scale of the opportunity on the table here.

You can access our full report today and discover for yourself just what Treatment’s AI platform could mean for the healthcare industry and how transformative it could be for the company itself.


Company Info is a disruptive healthcare technology startup that is harnessing the power of AI to help North Americans improve their health through personalized recommendations and insights.

Exchange / Symbol
Market Capitalization
$ (usd)
Current price
$ (usd)
Current mid price
$ (usd)
52 Week high price
$ (usd)
52 Week low price
$ (usd) International is an investment opportunity not to be missed.

Access our special report today to discover in more detail just how exciting an opportunity Treatment represents for smart investors. The time to take advantage is now.



This communication is a paid advertisement. ValueTheMarkets is a trading name of Digitonic Ltd, and its owners, directors, officers, employees, affiliates, agents and assigns (collectively the “Publisher”) is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher has been compensated by Treatment.Com International Inc. to conduct investor awareness advertising and marketing and has paid the Publisher the equivalent of two hundred and sixteen thousand US dollars to produce and disseminate this and other similar articles and certain related banner advertisements. This compensation should be viewed as a major conflict with the Publisher’s ability to provide unbiased information or opinion.


Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to adversely affect share prices. Frequently companies profiled in our articles experience a large increase in share trading volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in share trading volume and share price may likely occur.


This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security.


Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position.

This communication is based on information generally available to the public and on an interview conducted with the company’s CEO, and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher does not guarantee the accuracy or completeness of the information. Further, the information in this communication is not updated after publication and may become inaccurate or outdated. No reliance should be placed on the price or statistics information and no responsibility or liability is accepted for any error or inaccuracy. Any statements made should not be taken as an endorsement of analyst views.


The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser or a financial adviser. The Publisher has no access to non-public information about publicly traded companies. The information provided is general and impersonal, and is not tailored to any particular individual’s financial situation or investment objective(s) and this communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor or a personal recommendation to deal or invest in any particular company or product. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results.


This communication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. Statements in this communication that look forward in time, which include everything other than historical information, are based on assumptions and estimates by our content providers and involve risks and uncertainties that may affect the profiled company’s actual results of operations. These statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results and performance to differ materially from any future results or performance expressed or implied in the forward-looking statements. These risks, uncertainties and other factors include, among others: the success of the profiled company’s operations; the size and growth of the market for the company’s products and services; the company’s ability to fund its capital requirements in the near term and long term; pricing pressures; changes in business strategy, practices or customer relationships; general worldwide economic and business conditions; currency exchange and interest rate fluctuations; government, statutory, regulatory or administrative initiatives affecting the company’s business.


By reading this communication, you acknowledge that you have read and understand this disclaimer in full, and agree and accept that the Publisher provides no warranty in respect of the communication or the profiled company and accepts no liability whatsoever. You acknowledge and accept this disclaimer and that, to the greatest extent permitted under applicable law, you release and hold harmless the Publisher from any and all liability, damages, injury and adverse consequences arising from your use of this communication. You further agree that you are solely responsible for any financial outcome related to or arising from your investment decisions.


By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here and acknowledge that you have reviewed the Disclaimer found here If you do not agree to the Terms of Use, please contact to discontinue receiving future communications.


All trademarks used in this communication are the property of their respective trademark holders. Other than, the Publisher is not affiliated, connected, or associated with, and the communication is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks other than

AUTHORS: VALUETHEMARKETS and Digitonic Ltd and our affiliates are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above. This article does not provide any financial advice and is not a recommendation to deal in any securities or product. News and research are not recommendations to deal, and investments may fall in value so that you could lose some or all of your investment. Past performance is not an indicator of future performance.

ValueTheMarkets do not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above piece. ValueTheMarkets have been paid to produce this piece by the company or companies mentioned above. Digitonic Ltd, the owner of, has been paid for the production of this piece by the company or companies mentioned above.